This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saraiya, M. Articles by Stallings, F. L. Search for Related Content PubMed PubMed Citation Articles by Saraiya, M. Articles by Stallings, F. L.

Total and Percent Free Prostate-Specific Antigen Levels among U.S. Men, 2001-2002

¹ Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; ² Division of Health and Nutrition Examination Survey, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland; and ³ Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion

Requests for reprints: Mona Saraiya, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Mailstop K-55, Atlanta, GA 30341. Phone: 770-488-4293; Fax: 770-488-4639. E-mail: msaraiya{at}cdc.gov

Background: Because total prostate-specific antigen (PSA) and, more recently, the percent free PSA are used to screen men for prostate cancer, population-based, age- and race-specific distributions are needed of both PSA tests among American men to estimate the effect of lowering the PSA threshold or widespread introduction of the free PSA test as an additional screening test.

Methods: We did PSA assays on serum samples from men of ages 40 years and older (n = 1,320) who participated in the 2001-2002 National Health and Nutrition Examination Survey.

Results: About 6.1% (95% confidence interval, 4.7-7.7%), corresponding to an estimated 3.4 million (range, 2.7-4.3 million) men nationwide, ages 40 years and older, had a total PSA of >4.0 ng/mL. Among men ages 50 to 69 years old, the age group for which PSA testing is most prevalent, 5.4% or an estimated 900,000 to 2 million men had a total PSA of >4.0 ng/mL. An equal number had a total PSA between 2.5 and 4.0 ng/mL and a percent free PSA of <25%. Approximately 27% of men in this age group, corresponding to a range of 5.7 to 8.1 million men, had a total PSA <2.5 ng/mL and a percent free PSA of <25%.

Conclusion: The effect of lowering the total PSA threshold or introducing another screening test is significant. Provision of the number of U.S. men with certain total PSA and percent free PSA values may help guide prostate cancer public health policy and screening practices.

This article has been cited by other articles:

				D. M. Werny, T. Thompson, M. Saraiya, D. Freedman, B. J. Kottiri, R. R. German, and M. Wener Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004 Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 70 - 76. [Abstract] [Full Text] [PDF]

				D. M. Werny, M. Saraiya, and E. W. Gregg Prostate-specific Antigen Values in Diabetic and Nondiabetic US Men, 2001-2002 Am. J. Epidemiol., November 15, 2006; 164(10): 978 - 983. [Abstract] [Full Text] [PDF]